Capital Asset Advisory Services LLC Reduces Holdings in Procter & Gamble Company (The) $PG

Key Points

• Capital Asset Advisory Services LLC has reduced its holdings in Procter & Gamble by 13.5%, now owning 28,425 shares valued at $4.58 million.
• Several institutional investors, including Nuveen LLC and GAMMA Investing LLC, have significantly increased their stakes in Procter & Gamble during the first quarter of 2023, with GAMMA's stake growing by 20,758.5%.
• Procter & Gamble recently reported $1.48 earnings per share for the last quarter, exceeding analysts' expectations and indicating a year-over-year revenue growth of 1.7%.

Capital Asset Advisory Services LLC trimmed its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 13.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,425 shares of the company's stock after selling 4,441 shares during the period. Capital Asset Advisory Services LLC's holdings in Procter & Gamble were worth $4,583,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of PG. Nuveen LLC purchased a new stake in Procter & Gamble in the 1st quarter worth approximately $1,954,941,000. GAMMA Investing LLC grew its stake in Procter & Gamble by 20,758.5% in the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after acquiring an additional 7,913,335 shares during the period. Price T Rowe Associates Inc. MD grew its stake in Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares during the period. Invesco Ltd. grew its stake in Procter & Gamble by 19.8% in the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after acquiring an additional 2,228,151 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Procter & Gamble by 15.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock worth $2,728,430,000 after acquiring an additional 2,224,912 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, insider Marc S. Pritchard sold 9,849 shares of the business's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,548,952.23. Following the transaction, the insider owned 182,422 shares in the company, valued at $28,689,507.94. The trade was a 5.12% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Jon R. Moeller sold 40,119 shares of the business's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the completion of the transaction, the chief executive officer owned 319,375 shares in the company, valued at $50,228,106.25. This represents a 11.16% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 120,181 shares of company stock worth $18,918,012 over the last three months. Insiders own 0.20% of the company's stock.

Procter & Gamble Stock Down 0.4%

Shares of Procter & Gamble stock opened at $158.02 on Friday. The company has a fifty day moving average price of $156.21 and a 200 day moving average price of $161.84. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a twelve month low of $149.91 and a twelve month high of $180.43. The stock has a market cap of $369.85 billion, a price-to-earnings ratio of 24.27, a price-to-earnings-growth ratio of 4.19 and a beta of 0.36.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. During the same period in the prior year, the company earned $1.40 EPS. The firm's revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were issued a $1.0568 dividend. The ex-dividend date was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a yield of 2.7%. Procter & Gamble's payout ratio is currently 64.98%.

Analyst Ratings Changes

PG has been the subject of several recent analyst reports. Barclays set a $164.00 target price on shares of Procter & Gamble and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. UBS Group set a $180.00 price objective on shares of Procter & Gamble and gave the company a "buy" rating in a research note on Wednesday, July 30th. BNP Paribas reissued an "outperform" rating and set a $177.00 price objective on shares of Procter & Gamble in a research note on Friday, August 15th. JPMorgan Chase & Co. reissued a "neutral" rating and set a $170.00 price objective (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Finally, Evercore ISI reissued an "in-line" rating and set a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have issued a Hold rating to the company's stock. According to MarketBeat.com, Procter & Gamble has an average rating of "Moderate Buy" and an average target price of $175.12.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.